首页|紫杉醇联合表柔比星及护理干预治疗进展期乳腺癌的疗效研究

紫杉醇联合表柔比星及护理干预治疗进展期乳腺癌的疗效研究

扫码查看
目的 观察护理干预在采用紫杉醇+表柔比星化疗方案治疗的进展期乳腺癌患者临床疗效中的作用.方法 选取2015年4月~2017年4月在湖州市第一人民医院采用紫杉醇+表柔比星化疗方案进行治疗的74例进展期乳腺癌患者随机分为观察组与对照组,每组37例.对照组采用常规护理方法,观察组在对照组护理的基础上接受护理干预,比较2组临床缓解率.结果 观察组总缓解率为67.5%显著高于对照组43.2%(χ2=4.107,P<0.05).结论 配合实施护理干预能在一定程度上提高紫杉醇联合表柔比星化疗方案对进展期乳腺癌的治疗效果.
Efficacy of paclitaxel combined with epirubicin and nursing intervention in the treatment of advanced breast cancer
Objective To observe the effect of nursing intervention in clinical nursing care of patients with advanced breast cancer treated with paclitaxel plus epirubicin chemotherapy regimen. Methods 74 patients with advanced breast cancer who were treated with paclitaxel + epirubicin chemotherapy from April 2015 to April ~2017 were randomly divided into the observation group and the control group, 37 cases in each group. The control group received routine nursing care, the observation group received nursing intervention on the basis of the nursing care of the control group, and the clinical remission rate of the two groups was compared. Results The total remission rate in the observation group was 67.5%, significantly higher than that of the control group 43.2% (χ2=4.107, P<0.05). Conclusion Combined with the implementation of nursing intervention can improve the therapeutic effect of paclitaxel combined with epirubicin chemotherapy to advanced breast cancer to a certain extent.

paclitaxelepirubicinadvanced breast cancernursing intervention

林爱芳、陈玲萍

展开 >

湖州市第一人民医院 甲乳外科,浙江 湖州 313000

台州恩泽医疗中心(集团)恩泽医院 妇产科,浙江 台州318000

紫杉醇 表柔比星 进展期乳腺癌 护理干预

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(11)
  • 1
  • 7